Andrew Mark Pardoll is Director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy and Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics at Johns Hopkins University, School of Medicine. [1] [2] He is also Director of the Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center. [1]
He was educated at Johns Hopkins University (BA, MD, PhD). He was made a fellow of the American Association for Cancer Research in 2020. [3]
He has an h-index of 166 according to Google Scholar. [4]
Pardoll married Suzanne L. Topalian in 1993. [5]
The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.
The Faculty of Medicine and Health Sciences is one of the constituent faculties of McGill University. It was established in 1829 after the Montreal Medical Institution was incorporated into McGill College as the college's first faculty; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833.
Victor E. Velculescu is a Professor of Oncology and Co-Director of Cancer Biology at Johns Hopkins University School of Medicine. He is internationally known for his discoveries in genomics and cancer research.
Wafik El-Deiry is an American physician and cancer researcher who is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Brown University, Director of the Cancer Center at Brown University, and the Director of the Joint Program in Cancer Biology at Brown University and its affiliated hospitals. He was previously deputy director of Translational Research at Fox Chase Cancer Center, where he was also co-Leader of the Molecular Therapeutics Program.
Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Andrew Paul Feinberg is the director of the Center for Epigenetics, chief of the Division of Molecular Medicine in the Department of Medicine, and the King Fahd Professor of Medicine, Oncology, Molecular Biology & Genetics in the School of Medicine at Johns Hopkins University.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.
Donald Straley Coffey was the Catherine Lola and J. Smith Michael distinguished professor of Urology at the Johns Hopkins University School of Medicine and subsequently professor emeritus. He had a primary appointment to urology and secondary appointments to oncology, pharmacology and pathology.
Jennifer Hartt Elisseeff is an American biomedical engineer, ophthalmologist and academic. She is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical Engineering, Biomedical Engineering, Materials Science and Orthopedic Surgery. Elisseeff's research is in the fields of regenerative medicine and immunoengineering.
Alan Wayne Partin was an American prostate surgeon and researcher. He was the Jakurski Family Director of the Brady Urological Institute, Urologist-In-Chief of Johns Hopkins School of Medicine, and professor of Urology, Pathology, and Oncology. In 1993, he developed the PartinTables to help prostate cancer patients get an accurate prediction of their likelihood of being cured.
Suzanne Louise Topalian is an American surgical oncologist. She is the Bloomberg-Kimmel Professor of Cancer Immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine. In this role, she studies human anti-tumor immunity.
Eric Reese Fearon is an American oncologist. He is the Emanuel N. Maisel Professor of Oncology at the University of Michigan and director of the University of Michigan Rogel Cancer Center.
Andrew Ewald is a professor of cell biology at Johns Hopkins University School of Medicine. He is known for his contributions in the field of metastatic breast cancer research.
Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.
Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. He is known for his research on genetics, the MYC gene and the cellular energy metabolism of cancer.
Timothy Michael Pawlik is an American surgical oncologist. He is the Chair of the Department of Surgery and the Urban Meyer III and Shelley Meyer Chair for Cancer Research at Ohio State University and Surgeon-in-Chief at the Ohio State University Wexner Medical Center.
Julie Renee Brahmer is an American thoracic oncologist. She is the co-director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University and the Marilyn Meyerhoff Professor in Thoracic Oncology.
Andrea Lynn Richardson is an American pathologist and physician-scientist specialized in the molecular pathology of breast cancer. She is the Peter and Judy Kovler Professor in Breast Cancer Research and an associate professor of pathology and oncology at the Johns Hopkins School of Medicine. Richardson runs a clinic at the Sibley Memorial Hospital.
Cynthia Louise Sears is an American infectious disease physician-scientist specializing in food borne and intestinal infections. She is a professor of medicine, oncology, molecular biology, and immunology at the Johns Hopkins School of Medicine. She holds the Bloomberg-Kimmel Professorship of Cancer Immunotherapy.
Henry Brem, M.D. is an American neurosurgeon, researcher, educator and inventor known for introducing an image guidance computer system to deliver targeted chemotherapy to intraoperative brain tumors. As of 2023, he is the Harvey Cushing Professor, Director of the Department of Neurosurgery, Professor of Neurosurgery, Ophthalmology, Oncology and Biomedical Engineering Neurosurgeon-in-Chief, and Director, Hunterian Neurosurgical Research Center and Director at Johns Hopkins in Baltimore, Maryland. Brem has written more than 490 peer-reviewed articles, 50 books and book chapters and holds 11 patents.